UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 2.936

Sortiert nach

Oxaliplatin/capecitabine vs oxaliplatin/infusional 5-FU in advanced colorectal cancer: the MRC COIN trial

British journal of cancer, 2012-09, Vol.107 (7), p.1037-1043

2012

Link zum Volltext

Verfügbarkeit prüfen

A feasibility study testing four hypotheses with phase II outcomes in advanced colorectal cancer (MRC FOCUS3): a model for randomised controlled trials in the era of personalised medicine?

British journal of cancer, 2014-04, Vol.110 (9), p.2178-2186

2014

Link zum Volltext

Verfügbarkeit prüfen

Toxicity associated with combination oxaliplatin plus fluoropyrimidine with or without cetuximab in the MRC COIN trial experience

British journal of cancer, 2009-01, Vol.100 (2), p.251-258

2009

Link zum Volltext

Verfügbarkeit prüfen

Fatal case of sorafenib-associated idiosyncratic hepatotoxicity in the adjuvant treatment of a patient with renal cell carcinoma

BMC cancer, 2012-12, Vol.12 (1), p.590-590, Article 590

2012

Link zum Volltext

Verfügbarkeit prüfen

Common and rare DPYD variants are predictive for 5FU/capecitabine (5FU) toxicity: The MRC COIN and COIN-B trials

Annals of oncology, 2018-10, Vol.29, p.viii22-viii22

2018

Link zum Volltext

Verfügbarkeit prüfen

Predicting vasovagal reactions in volunteer blood donors

Journal of psychosomatic research, 1996-05, Vol.40 (5), p.495-501

1996

Link zum Volltext

Verfügbarkeit prüfen

Post-injury substance abuse among persons with brain injury and persons with spinal cord injury

Brain injury, 2002-07, Vol.16 (7), p.583-592

2002

Link zum Volltext

Verfügbarkeit prüfen

Improving Mental Health Service Utilization Among Men: A Systematic Review and Synthesis of Behavior Change Techniques Within Interventions Targeting Help-Seeking

American Journal of Men's Health, 2019-05, Vol.13 (3), p.1557988319857009-1557988319857009

2019

Link zum Volltext

Verfügbarkeit prüfen

Exteroceptive suppression of temporalis and masseter muscle activity is enhanced in offspring of hypertensives

Psychophysiology, 1996-09, Vol.33 (5), p.601-604

1996

Link zum Volltext

Verfügbarkeit prüfen

Specific inhibition of cyclin-dependent kinase 4/6 by PD 0332991 and associated antitumor activity in human tumor xenografts

Molecular cancer therapeutics, 2004-11, Vol.3 (11), p.1427-1438

2004

Link zum Volltext

Verfügbarkeit prüfen

Outcomes of early surgical management versus late or no surgical intervention after acute spinal cord injury

Archives of physical medicine and rehabilitation, 2004-11, Vol.85 (11), p.1818-1825

2004

Link zum Volltext

Verfügbarkeit prüfen

Environmental factors and their role in participation and life satisfaction after spinal cord injury

Archives of physical medicine and rehabilitation, 2004-11, Vol.85 (11), p.1793-1803

2004

Link zum Volltext

Verfügbarkeit prüfen

Patterns of alcohol and substance use and abuse in persons with spinal cord injury: Risk factors and correlates

Archives of physical medicine and rehabilitation, 2004-11, Vol.85 (11), p.1837-1847

2004

Link zum Volltext

Verfügbarkeit prüfen

A systematic review of randomized controlled trials (RCTs) of EGFR-targeted monoclonal antibody (MAb) therapy in advanced colorectal cancer (ACRC): Impact of KRAS status

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.e14001-e14001

2010

Link zum Volltext

Verfügbarkeit prüfen

Identification of potentially responsive subsets when cetuximab is added to oxaliplatin-fluoropyrimidine chemotherapy (CT) in first-line advanced colorectal cancer (aCRC): Mature results of the MRC COIN trial

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.3502-3502

2010

Link zum Volltext

Verfügbarkeit prüfen

Intermittent versus continuous oxaliplatin-fluoropyrimidine (Ox-Fp) chemotherapy (CT) in first-line treatment of patients (pts) with advanced colorectal cancer (aCRC): Predictive factors (PF), quality of life (QL), and final efficacy results from the MRC COIN trial

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.3525-3525

2010

Link zum Volltext

Verfügbarkeit prüfen

Race, employment, and spinal cord injury

Archives of physical medicine and rehabilitation, 2004-11, Vol.85 (11), p.1782-1792

2004

Link zum Volltext

Verfügbarkeit prüfen

583PChoosing the right strategy based on individualized treatment effect predictions: Combination versus sequential chemotherapy in patients with metastatic colorectal cancer

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Link zum Volltext

Verfügbarkeit prüfen

Developing a biomarker-stratified trial design in advanced colorectal cancer: The MRC FOCUS 3 feasibility study

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.TPS165-TPS165

2011

Link zum Volltext

Verfügbarkeit prüfen

Traumatic brain injury and substance abuse: A review and analysis of the literature

Neuropsychological rehabilitation, 2003-01, Vol.13 (1-2), p.165-188

2003

Link zum Volltext

Verfügbarkeit prüfen

LBA56Primary efficacy analysis results from the SORCE trial (RE05): Adjuvant sorafenib for renal cell carcinoma at intermediate or high risk of relapse: An international, randomised double-blind phase III trial led by the MRC CTU at UCL

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Link zum Volltext

Verfügbarkeit prüfen

Participation in recreation and sports for persons with spinal cord injury: review and recommendations

NeuroRehabilitation (Reading, Mass.), 2004-01, Vol.19 (2), p.121

2004

Link zum Volltext

Verfügbarkeit prüfen

74PCommon and rare DPYD variants are predictive for 5FU/capecitabine (5FU) toxicity: The MRC COIN and COIN-B trials

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 2.936

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.532)
Mit Volltextzugriff
(2.482)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(17)
... seit 30 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Oxaliplatin/capecitabine vs oxaliplatin/infusional 5-FU in advanced colorectal cancer: the MRC COIN trial

A feasibility study testing four hypotheses with phase II outcomes in advanced colorectal cancer (MRC FOCUS3): a model for randomised controlled trials in the era of personalised medicine?

Toxicity associated with combination oxaliplatin plus fluoropyrimidine with or without cetuximab in the MRC COIN trial experience

Fatal case of sorafenib-associated idiosyncratic hepatotoxicity in the adjuvant treatment of a patient with renal cell carcinoma

Common and rare DPYD variants are predictive for 5FU/capecitabine (5FU) toxicity: The MRC COIN and COIN-B trials

Predicting vasovagal reactions in volunteer blood donors

Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial

Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial

Post-injury substance abuse among persons with brain injury and persons with spinal cord injury

Improving Mental Health Service Utilization Among Men: A Systematic Review and Synthesis of Behavior Change Techniques Within Interventions Targeting Help-Seeking

Exteroceptive suppression of temporalis and masseter muscle activity is enhanced in offspring of hypertensives

Specific inhibition of cyclin-dependent kinase 4/6 by PD 0332991 and associated antitumor activity in human tumor xenografts

Outcomes of early surgical management versus late or no surgical intervention after acute spinal cord injury

Environmental factors and their role in participation and life satisfaction after spinal cord injury

Patterns of alcohol and substance use and abuse in persons with spinal cord injury: Risk factors and correlates

A systematic review of randomized controlled trials (RCTs) of EGFR-targeted monoclonal antibody (MAb) therapy in advanced colorectal cancer (ACRC): Impact of KRAS status

Identification of potentially responsive subsets when cetuximab is added to oxaliplatin-fluoropyrimidine chemotherapy (CT) in first-line advanced colorectal cancer (aCRC): Mature results of the MRC COIN trial

Intermittent versus continuous oxaliplatin-fluoropyrimidine (Ox-Fp) chemotherapy (CT) in first-line treatment of patients (pts) with advanced colorectal cancer (aCRC): Predictive factors (PF), quality of life (QL), and final efficacy results from the MRC COIN trial

Race, employment, and spinal cord injury

583PChoosing the right strategy based on individualized treatment effect predictions: Combination versus sequential chemotherapy in patients with metastatic colorectal cancer

Developing a biomarker-stratified trial design in advanced colorectal cancer: The MRC FOCUS 3 feasibility study

Traumatic brain injury and substance abuse: A review and analysis of the literature

LBA56Primary efficacy analysis results from the SORCE trial (RE05): Adjuvant sorafenib for renal cell carcinoma at intermediate or high risk of relapse: An international, randomised double-blind phase III trial led by the MRC CTU at UCL

Participation in recreation and sports for persons with spinal cord injury: review and recommendations

74PCommon and rare DPYD variants are predictive for 5FU/capecitabine (5FU) toxicity: The MRC COIN and COIN-B trials

Suchergebnisse filtern